Big Pharma’s Hunt for New Drugs Is Pushing Up Cost of Deals. Mergers, Acquisitions and Divestitures, Drugs (Pharmaceuticals), Biotechnology and Bioengineering, Stocks and Bonds, Bristol Myers Squibb Company, Celgene Corporation, Eli Lilly and Company, Roche Holding AG